Endurant Capital Management LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,775,000
-23.4%
71,640
+19.9%
0.62%
+2.1%
Q1 2022$2,316,000
+6.0%
59,732
+60.0%
0.61%
+15.7%
Q4 2021$2,184,000
-50.7%
37,325
-26.9%
0.53%
-56.7%
Q2 2021$4,429,000
+300.1%
51,031
+279.9%
1.22%
+321.1%
Q1 2021$1,107,000
-81.7%
13,432
-79.8%
0.29%
-86.8%
Q4 2020$6,055,000
+169.5%
66,585
+18.5%
2.18%
+228.9%
Q3 2020$2,247,000
+7.6%
56,210
-7.7%
0.66%
+477.4%
Q2 2020$2,089,000
+130.8%
60,892
+49.5%
0.12%
-72.0%
Q1 2020$905,000
-65.7%
40,732
-69.8%
0.41%
-50.7%
Q4 2019$2,642,000
+2.0%
135,022
-19.0%
0.83%
-10.5%
Q3 2019$2,590,000
-22.2%
166,782
-18.4%
0.93%
-37.2%
Q3 2018$3,329,000
+255.7%
204,333
+147.5%
1.48%
+264.8%
Q2 2018$936,000
-38.3%
82,572
-46.8%
0.41%
-28.3%
Q1 2018$1,516,000
-55.4%
155,344
-72.1%
0.57%
-45.6%
Q4 2017$3,401,000
+214.9%
556,679
+104.1%
1.04%
+218.0%
Q3 2017$1,080,000272,7000.33%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders